Ubs Group Ag Sonendo, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.53 - $2.71 $10,462 - $18,530	-6,838 Reduced 19.86%	27,590 $55,000
Q4 2022 Feb 08, 2023	SELL	$1.11 - $2.9 $6,118 - $15,984	-5,512 Reduced 13.8%	34,428 $97,000
Q3 2022 Nov 10, 2022	SELL	$0.91 - $2.09 $738 - $1,694	-811 Reduced 1.99%	39,940 $43,000
Q2 2022 Aug 10, 2022	BUY	$1.72 - $3.73 $1,394 - $3,025	811 Added 2.03%	40,751 $70,000
Q1 2022 May 16, 2022	SELL	$3.12 - $8.17 $12,607 - $33,014	-4,041 Reduced 9.19%	39,940 $160,000
Q4 2021 Feb 14, 2022	BUY	$5.72 - $11.56 $251,571 - $508,420	43,981 New	43,981 $254,000

7.78M

Ticker SONX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,661,200
Market Cap $105M
Description
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company a...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.